Alpha 2.0
Login Register
» Authors » F Westermann

F Westermann

Explore the profile of F Westermann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 1060
Followers 0
Related Specialties
Molecular Biology
Oncology
General Medicine
Top 10 Co-Authors
M Fischer
F Berthold
A Eggert
B Brors
A Schramm
B Hero
J Theissen
F Speleman
A Oberthuer
C Kumps
Published In
Oncogene
Zentralbl Bakteriol Orig A
Eur J Endocrinol
Pharmacogenomics J
Ann Oncol
Affiliations
Soon will be listed here.
Recent Articles
11.
Risk estimation of neuroblastoma patients using molecular markers
Fischer M, Spitz R, Oberthur A, Westermann F, Berthold F
Klin Padiatr . 2008 May; 220(3):137-46. PMID: 18478485
The pediatric tumor neuroblastoma is a heterogeneous disease: Patients' clinical courses can range from spontaneous regression to fatal progression of the disease. Accordingly, treatment protocols vary from "wait and see"...
12.
Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma
Nowacki S, Skowron M, Oberthuer A, Fagin A, Voth H, Brors B, et al.
Oncogene . 2007 Dec; 27(23):3329-38. PMID: 18084322
Cell adhesion molecule 1 (CADM1) is a putative tumour suppressor gene, which is downregulated in many solid tumours. In neuroblastoma, loss of CADM1 expression has recently been found in disseminated...
13.
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
Khan J, Wei J, Ringner M, Saal L, Ladanyi M, Westermann F, et al.
Nat Med . 2001 Jun; 7(6):673-9. PMID: 11385503
The purpose of this study was to develop a method of classifying cancers to specific diagnostic categories based on their gene expression signatures using artificial neural networks (ANNs). We trained...
14.
Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia
Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham M, Ritter H, et al.
Nat Genet . 2001 Apr; 28(1):37-41. PMID: 11326272
Craniometaphyseal dysplasia (CMD) is a bone dysplasia characterized by overgrowth and sclerosis of the craniofacial bones and abnormal modeling of the metaphyses of the tubular bones. Hyperostosis and sclerosis of...
15.
A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency
Schonau E, Westermann F, Rauch F, Stabrey A, Wassmer G, Keller E, et al.
Eur J Endocrinol . 2001 Feb; 144(1):13-20. PMID: 11174832
Objective: To identify parameters which predict individual growth response to recombinant human GH (rhGH) therapy and to combine these parameters in a prediction model. Design: Fifty-eight prepubertal patients with GH...
16.
Serum leptin is suppressed by growth hormone therapy in growth hormone-deficient children
Rauch F, Westermann F, Englaro P, Blum W, Schonau E
Horm Res . 1998 Aug; 50(1):18-21. PMID: 9691208
Leptin is a hormone which is exclusively synthesized and secreted by adipocytes. As of yet, little is known about the complex interplay of hormones in the modulation of circulating leptin...
17.
Interleukin 10 inhibits cytokine production of human AML cells
Westermann F, Kube D, Haier B, Bohlen H, Engert A, Zuehlsdorf M, et al.
Ann Oncol . 1996 Apr; 7(4):397-404. PMID: 8805932
Background: Unlike normal hematopoietic cells leukemic blasts from patients with AML constitutively express cytokines like IL1, GM-CSF and TNF alpha and it has been suggested that these cytokines may regulate...
18.
[Study on the effect of formaldehyde on the immunological reactivity and morphology of hepatitis B-antigen (author's transl)]
Westermann F, Tripatzis I, Luciano L
Zentralbl Bakteriol Orig A . 1978 Apr; 240(2):143-51. PMID: 418600
Treatment of purified HB-antigen with formaldehyde solution changes its immunological reactivity and its morphology. A decrease in antigen activity by formaldehyde treatment could be demonstrated by radial immunodiffusion and by...